Coldstream Capital Management Inc Repligen Corp Transaction History

Coldstream Capital Management Inc

  • $3.92 Billion
  • Q1 2024

A detailed history of Coldstream Capital Management Inc transactions in Repligen Corp stock. As of the latest transaction made, Coldstream Capital Management Inc holds 2,272 shares of RGEN stock, worth $272,958. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,272
Previous 2,221 2.3%
Holding current value
$272,958
Previous $399,000 4.51%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$170.78 - $208.42 $8,709 - $10,629
51 Added 2.3%
2,272 $417,000
Q4 2023

Feb 09, 2024
SELL
$114.17 - $185.35 $22,605 - $36,699
-198 Reduced 8.19%
2,221 $399,000
Q3 2023

Nov 02, 2023
BUY
$138.78 - $176.51 $6,245 - $7,942
45 Added 1.9%
2,419 $384,000
Q2 2023

Aug 03, 2023
SELL
$138.42 - $180.31 $10,935 - $14,244
-79 Reduced 3.22%
2,374 $335,000
Q1 2023

May 15, 2023
BUY
$154.26 - $198.1 $4,936 - $6,339
32 Added 1.32%
2,453 $412,000
Q4 2022

Jan 10, 2023
BUY
$162.42 - $220.56 $20,140 - $27,349
124 Added 5.4%
2,421 $0
Q2 2022

Aug 08, 2022
SELL
$140.68 - $188.02 $297,819 - $398,038
-2,117 Closed
0 $0
Q2 2022

Aug 08, 2022
BUY
$140.68 - $188.02 $323,141 - $431,881
2,297 New
2,297 $373,000
Q1 2022

May 11, 2022
SELL
$161.19 - $257.96 $44,004 - $70,423
-273 Reduced 11.42%
2,117 $398,000
Q4 2021

Feb 11, 2022
BUY
$247.59 - $304.47 $591,740 - $727,683
2,390 New
2,390 $633,000
Q3 2021

Nov 12, 2021
SELL
$194.77 - $324.21 $213,078 - $354,685
-1,094 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$165.87 - $220.95 $9,454 - $12,594
57 Added 5.5%
1,094 $218,000
Q1 2021

Jun 16, 2021
BUY
$180.37 - $226.26 $187,043 - $234,631
1,037 New
1,037 $202,000

Others Institutions Holding RGEN

# of Institutions
522
Shares Held
53.2M
Call Options Held
1.05M
Put Options Held
228K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $6.67B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Coldstream Capital Management Inc Portfolio

Follow Coldstream Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coldstream Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Coldstream Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email